RVPH
Reviva
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RVPH Profile
Reviva Pharmaceuticals Holdings, Inc.
A clinical-stage pharmaceutical company that develops therapies for central nervous system, cardiovascular, metabolic, and inflammatory diseases
10080 N. Wolfe Road, Suite SW3-200, Cupertino, CA 95014
--
Reviva Pharmaceuticals Holdings, Inc. was incorporated in the British Virgin Islands on March 20, 2018. The Company is a late-stage pharmaceutical company dedicated to discovering, developing and seeking to commercialize next-generation treatments for diseases that have significant unmet medical needs and burdens on society, patients and their families. Their current product lines focus on central nervous system, inflammation and cardiometabolic diseases.